Your browser doesn't support javascript.
loading
Including a general practice endorsement letter with the testing kit in the Bowel Cancer Screening Programme: Results of a cluster randomised trial.
Cross, Amanda J; Myles, Jonathan; Greliak, Paul; Hackshaw, Allan; Halloran, Stephen; Benton, Sally C; Addison, Caroline; Chapman, Caroline; Djedovic, Natasha; Smith, Stephen; Wagner, Christian von; Duffy, Stephen W; Raine, Rosalind.
Afiliação
  • Cross AJ; Department of Surgery and Cancer, Imperial College London, London, UK.
  • Myles J; Wolfson Institute for Preventive Medicine, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
  • Greliak P; Department of Surgery and Cancer, Imperial College London, London, UK.
  • Hackshaw A; Cancer Research UK and UCL Cancer Trials Centre, Cancer Institute, University College London, London, UK.
  • Halloran S; Bowel Cancer Screening Southern Programme Hub, Surrey Research Park, Guildford, UK.
  • Benton SC; Department of Biomedical Sciences, University of Surrey, Guildford, UK.
  • Addison C; Bowel Cancer Screening Southern Programme Hub, Surrey Research Park, Guildford, UK.
  • Chapman C; Berkshire and Surrey Pathology Services, Royal Surrey County Hospital, Guildford, UK.
  • Djedovic N; Bowel Cancer Screening North East Programme Hub, Queen Elizabeth Hospital, Gateshead, UK.
  • Smith S; Bowel Cancer Screening Eastern Programme Hub, University of Nottingham, Nottingham, UK.
  • Wagner CV; Bowel Cancer Screening London Programme Hub, Northwick Park & St Mark's Hospitals, Harrow, UK.
  • Duffy SW; Bowel Cancer Screening Midlands & North West Programme Hub, Hospital of St Cross, Rugby, UK.
  • Raine R; Department of Applied Health Research, University College London, London, UK.
J Med Screen ; 28(4): 419-425, 2021 12.
Article em En | MEDLINE | ID: mdl-33645308
ABSTRACT

OBJECTIVES:

To evaluate the effect of general practitioner endorsement accompanying the screening kit rather than with the invitation letter on participation in the NHS Bowel Cancer Screening Programme and on the socioeconomic gradient in participation in the Programme.

METHODS:

The NHS Bowel Cancer Screening Programme in England is delivered via five regional hubs. In early 2016, we carried out a cluster-randomised trial, with hub-day of invitation as the randomisation unit. We randomised 150 hub-days of invitation to the intervention group, GP endorsement on the letter accompanying the guaiac faecal occult blood testing kit (75 hub-days, 197,366 individuals) or control, usual letter (75 hub-days, 197,476 individuals). The endpoint was participation, defined as return of a valid kit within 18 weeks of initial invitation. Because of the cluster randomisation, data were analysed by a hierarchical logistic regression, allowing a random effect for date of invitation. Socioeconomic status was represented by the index of multiple deprivation.

RESULTS:

Participation was 59.4% in the intervention group and 58.7% in the control group, a significant difference (p = 0.04). There was no heterogeneity of the effect of intervention by index of multiple deprivation. We found that there was some confounding between date and screening episode order (first or subsequent screen). This in turn may have induced confounding with age and slightly diluted the result.

CONCLUSIONS:

General practitioner endorsement induces a modest increase in participation in bowel cancer screening, but does not affect the socioeconomic gradient. When considering cluster randomisation as a research method, careful scrutiny of potential confounding is indicated in advance if possible and in analysis otherwise.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Medicina Geral Tipo de estudo: Clinical_trials / Diagnostic_studies / Prognostic_studies / Screening_studies Limite: Humans Idioma: En Revista: J Med Screen Assunto da revista: EPIDEMIOLOGIA / SAUDE PUBLICA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Medicina Geral Tipo de estudo: Clinical_trials / Diagnostic_studies / Prognostic_studies / Screening_studies Limite: Humans Idioma: En Revista: J Med Screen Assunto da revista: EPIDEMIOLOGIA / SAUDE PUBLICA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Reino Unido